Romans Zukovs

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

U. Germing, G. Kobbe, R. Fenk, 2022, Cancers.

18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?

G. Antoch, C. Antke, H. Müller, 2022, BMC Medical Imaging.

Feasibility of quantitative susceptibility mapping (QSM) of the human kidney

H. Wittsack, A. Ljimani, B. Valentin, 2020, Magnetic Resonance Materials in Physics, Biology and Medicine.